122 related articles for article (PubMed ID: 20210789)
1. A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins.
Lacchini R; Silva PS; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):357-61. PubMed ID: 20210789
[TBL] [Abstract][Full Text] [Related]
2. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
[TBL] [Abstract][Full Text] [Related]
3. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite.
Nagassaki S; Sertório JT; Metzger IF; Bem AF; Rocha JB; Tanus-Santos JE
Free Radic Biol Med; 2006 Oct; 41(7):1044-9. PubMed ID: 16962929
[TBL] [Abstract][Full Text] [Related]
4. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
6. Differences between statins on clinical endpoints: a population-based cohort study.
Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
[TBL] [Abstract][Full Text] [Related]
7. The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients.
Rossi GP; Maiolino G; Zanchetta M; Sticchi D; Pedon L; Cesari M; Montemurro D; De Toni R; Zavattiero S; Pessina AC
J Am Coll Cardiol; 2006 Sep; 48(6):1166-74. PubMed ID: 16979000
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of LOX-1 by statins may relate to upregulation of eNOS.
Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F
Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics.
Hoffmann IS; Tavares-Mordwinkin R; Castejon AM; Alfieri AB; Cubeddu LX
J Hum Hypertens; 2005 Mar; 19(3):233-40. PubMed ID: 15565175
[TBL] [Abstract][Full Text] [Related]
10. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
11. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells.
Ohkita M; Sugii M; Ka Y; Kitamura A; Mori T; Hayashi T; Takaoka M; Matsumura Y
Exp Biol Med (Maywood); 2006 Jun; 231(6):772-6. PubMed ID: 16740997
[TBL] [Abstract][Full Text] [Related]
13. Statins activate AMP-activated protein kinase in vitro and in vivo.
Sun W; Lee TS; Zhu M; Gu C; Wang Y; Zhu Y; Shyy JY
Circulation; 2006 Dec; 114(24):2655-62. PubMed ID: 17116771
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene.
Souza-Costa DC; Sandrim VC; Lopes LF; Gerlach RF; Rego EM; Tanus-Santos JE
Atherosclerosis; 2007 Aug; 193(2):438-44. PubMed ID: 16938300
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin preconditioning attenuates the production of endothelin-1 and prevents experimental vasospasm in rats.
Chang CZ; Wu SC; Lin CL; Hwang SL; Howng SL; Kwan AL
Acta Neurochir (Wien); 2010 Aug; 152(8):1399-406; discussion 1405-6. PubMed ID: 20440630
[TBL] [Abstract][Full Text] [Related]
16. Intron 4 polymorphism of the endothelial nitric oxide synthase (eNOS) gene is associated with decreased NO production in a mercury-exposed population.
de Marco KC; Antunes LM; Tanus-Santos JE; Barbosa F
Sci Total Environ; 2012 Jan; 414():708-12. PubMed ID: 22134029
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S
Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618
[TBL] [Abstract][Full Text] [Related]
18. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia.
Sandrim VC; Palei AC; Sertorio JT; Cavalli RC; Duarte G; Tanus-Santos JE
Mol Hum Reprod; 2010 Jul; 16(7):506-10. PubMed ID: 20457799
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic statins as a possible method to decrease bubble formation in diving.
Duplessis CA; Fothergill D; Schwaller D; Hughes L; Gertner J
Aviat Space Environ Med; 2007 Apr; 78(4):430-4. PubMed ID: 17484348
[TBL] [Abstract][Full Text] [Related]
20. Association between achalasia and nitric oxide synthase gene polymorphisms.
Mearin F; García-González MA; Strunk M; Zárate N; Malagelada JR; Lanas A
Am J Gastroenterol; 2006 Sep; 101(9):1979-84. PubMed ID: 16848803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
